Stay updated on Efruxifermin in NASH Subjects Clinical Trial
Sign up to get notified when there's something new on the Efruxifermin in NASH Subjects Clinical Trial page.

Latest updates to the Efruxifermin in NASH Subjects Clinical Trial page
- CheckyesterdayChange DetectedThe related topics entries 'Non-alcoholic fatty liver disease' and 'MedlinePlus Genetics' were removed from the page. This affects only navigation in the related topics area and does not alter the study details.SummaryDifference0.1%

- Check8 days agoChange DetectedThe page content remains substantially the same with no additions or deletions to core sections (eligibility, outcomes, arms, or locations); any observed differences appear to be formatting/layout or non-substantive data presentation changes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check15 days agoNo Change Detected
- Check37 days agoChange DetectedUpdated the revision label from v3.0.2 to v3.2.0, indicating a newer version has been released. No other content changes observed.SummaryDifference0.1%

- Check38 days agoChange DetectedReleased a new revision (v3.1.0) and removed a related topic: MedlinePlus Genetics topic on Non-alcoholic fatty liver disease as part of the prior revision v3.0.2.SummaryDifference0.4%

- Check45 days agoChange DetectedCore content on drug safety and related topics has been removed, reducing important information about drug safety, counterfeit drugs, pharmaceutical preparations, and substandard drugs.SummaryDifference0.3%

- Check52 days agoChange DetectedAdded a MedlinePlus Genetics topic: Non-alcoholic fatty liver disease and updated the page to v3.0.2; removed the old revision tag (v3.0.1) and the Back to Top link.SummaryDifference0.5%

Stay in the know with updates to Efruxifermin in NASH Subjects Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efruxifermin in NASH Subjects Clinical Trial page.